Therapeutic Effects of Instrument-assisted Versus Sound-assisted Soft Tissue Mobilization in Chronic Non-specific Low Back Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-55
SponsorUniversity of Lahore

About this trial

Chronic low back pain (CLBP) is the most common medical problem observed among musculoskeletal pain and spinal pain problems. It can reduce the movements due to muscular imbalances, decreased activity of daily living, and effects on health-related quality of life. It is the major cause of activity limitation, work absence, and reported clinical issues. Most of the cases of low back pain remained undiagnosed and received only symptomatic management.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pain between the inferior gluteal folds and the costal margins.

Pain with a duration of a minimum of 24 weeks.

Moderate to severe pain (>3) was measured using the Numeric Pain Rating Scale.

Straight Leg raise Limited (hamstring tightness)

Disqualifiers

Pain in lower back with radiating/referring but limited to proximal legs

Pain for the last 03 months and at least half of the days in the last six months.

Presence of neurological problem/deficit/disease (e.g., nerve root compression, motor deficit, paresthesia) and lower limb symptoms.

Presence of disease like Infection, tumors, spondylolisthesis grade II or higher, vertebral fractures, identifiable cause like endometriosis

Trial design

Design model

Parallel

Treatments tested in this trial

  • SASTM

    Device

    The therapist will apply sound instrument-assisted soft tissue mobilization (SASTM) with a convex plastic (Ceramic) tool (Beer JA, 2019).

  • IASTM

    Device

    The IASTM technique contains a protocol for treatment that contains five components: i. Examination, ii. warm-up exercises 5 min iii. IASTM treatment (e.g., 30-60 seconds per session), iv. Post treatment stretching and strengthening, v. Icing (only when sub-acute inflammation is of concern).

  • Exercise

    Other intervention

    In conventional therapy, patients will be given an exercise program that will be targeted to low back muscles. This will be include three type of exercise focusing on stretching, strengthening and postural correction exercise.(Yana et al., 2024)

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Group AActive comparator 2 interventions
Group B: Group BExperimental treatment 2 interventions
Group C: Group COther 1 intervention

Trial outcomes

Primary outcomes

1

Pain Intensity

The pain will be assessed using Chronic Pain grading Scale (CPGS).

Time frame
Pain intensity will be noted at baseline ,after the 2nd week, 3rd week, 4th week, and follow up will be taken at 2nd month, and after the 4th month post intervention.
2

Flexibility

Modified-Modified Schober Test will be used to measure Lumbar flexibility.

Time frame
The lumbar flexibility will be noted at basline after the 2nd week, 3rd week, 4th week, and follow up will be taken at 2nd month, and after the 4th month post intervention.

Secondary outcomes

1

Function

Functional movement Screen (FMS) will be used.

Time frame
The functional movement screening will be noted at baseline, after the 2nd week, 3rd week, 4th week, and follow up will be taken at 2nd month, and after the 4th month post intervention.
2

Disability

Roland Morris Disability Index will be used to measure disability Index.

Time frame
Disability will be assessed before treatment, after the 2nd month, and 4th month post-intervention.
3

Hamstring Flexibility

Active knee Extension Test will be used to assess hamstring Flexibility.

Time frame
Hamstring flexibility will be measured at basline, 2nd month, and after the 4th month post intervention.

Other outcomes

1

Pelvic obliquity

Leg length difference will be measured as an indicator of pelvic obliquity.

Time frame
The pelvic obliquity will be assessed before treatment, after 2nd month and 4th month post-intervention.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.